Category: Trump Administration

Trump Approves Final Plan to Import Drugs From Canada ‘for a Fraction of the Price’

The announcement clears the way for Florida and other states to implement a program bringing medications across the border to save money. The effort is strongly opposed by drugmakers and the Canadian government.

KHN’s ‘What the Health?’: ACA in Peril With Ginsburg’s Seat in Play

The death of Supreme Court Justice Ruth Bader Ginsburg is giving new life to the latest constitutional challenge to the Affordable Care Act. It also places anti-abortion activists on the cusp of a court majority large enough to ensure the rollback of the right to abortion and, possibly, some types of birth control. Meanwhile, Health and Human Services Secretary Alex Azar tries to centralize power at the sprawling department plagued by miscommunications and scandals. Anna Edney of Bloomberg News, Kimberly Leonard of Business Insider and Mary Ellen McIntire of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Sarah Jane Tribble about her new podcast, “Where It Hurts,” debuting Sept. 29.

Election Gift for Florida? Trump Poised to Approve Drug Imports From Canada

The Trump administration is primed to approve a plan designed to help lower costs of some prescription drugs by allowing states to import them from Canada. The announcement could come before Election Day, and Florida appears to be in line to go first.

KHN’s ‘What the Health?’: It’s Scandal Week

President Donald Trump this week issued a prescription drug pricing order unlikely to lower drug prices, and he contradicted comments by his director of the Centers for Disease Control and Prevention on the need for mask-wearing and predictions for vaccine availability. Meanwhile, scandals erupted at the CDC, the Centers for Medicare & Medicaid Services and the Food and Drug Administration. And the number of people without health insurance grew in 2019, reported the Census Bureau, even while the economy soared. Alice Miranda Ollstein of Politico, Tami Luhby of CNN and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

KHN’s ‘What the Health?’: The Politics of Science

Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.

Most Adults Wary of Taking Any Vaccine Approved Before the Election

About 60% of poll respondents are worried that federal regulators will rush to allow a vaccine because of political pressure. Opposition to getting a vaccine that might be authorized before the November election is strongest among Republicans.

HHS Plan to Improve Rural Health Focuses on Better Broadband, Telehealth Services

The proposal details a wide-ranging agenda to remedy the gaps in health care and myriad challenges in rural America. In addition to more telehealth options, it includes shifts in hospital payments and expanded funding for school-based mental health programs.

Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims

Donald Trump accepted his party’s nomination to seek reelection for a second term as president in front of a partisan audience that appeared to largely lack masks and opt against social distancing.

5 Things to Know About Convalescent Blood Plasma

President Donald Trump touted the Food and Drug Administration’s approval of this unproven COVID-19 treatment for emergency use. That set off reactions ranging from excitement and optimism to scientific concerns and criticism that the decision was politically motivated.

Republican Convention, Day 3: Revisionist History

Vice President Mike Pence officially accepted the Republican Party’s nomination for a second term.